|
|
Post by dreamboatcruise on Jan 15, 2015 14:29:33 GMT -5
Anyone know how much a spirometer costs?
|
|
|
|
Post by dreamboatcruise on Jan 15, 2015 14:34:15 GMT -5
To be fair I believe the 3.1M was presented by SNY as the initial target population... not a sales projection.
|
|
|
|
Post by alethea on Jan 15, 2015 14:49:12 GMT -5
I think fugacity is right on track. This is all manipulation to turn around the short position. Know it for what it is and play accordingly. The elimination of the uptick rule in 2007 among other regulatory loosenings has allowed these thieves to drive the price down at their will. To say nothing of naked shorting. What about the 9M shares MNKD lent to Bank America and the related(?) 100M Convertible Debt? Do you not think that PPS will be bound by the $5.50 convertible price until the convertible debt comes due in August, 2015? Doesn't Bank of America have to repay the 9M shares at that time? Or has that obligation been shifted/transferred to repaying the 100M convertible debt? In any event they will not lose on the repayment. Hindsight is 20/20. It is blatantly obvious looking backward that MKND's PPS has been utterly manipulated, with the clear winning position being the short side. Ironically, the engagement of Deerfield, which most of us hailed as a positive in terms of PPS, has done nothing to prevent and I believe, has participated in egregious manipulation ressulting in vast profits for shorts, including Bank America and Deerfield themselves. They even say so in the fine print of the legal filings. That PPS may go up or down and we (B of A, or whoever) may taking hedging short positions. BUT, it is stunningly clear such manipulation has occured resulting in hundreds of millions of profits for the shorts. Sadly, the crooks will know when to ultimately switch to the long side. After all they are the ones with their thumbs on the scale. Looking at tomorrow's expiring options, I ABSOUTELY GUARANTEE that the cheats SOLD most of the 175K Calls (in the money) to unfortunate true blue longs. (I am one of the suckers who got fleeced on tomorrow's Calls that I bought a year and a half ago. Silly me who thought FDA approval and product launch would cause the PPS to rise.) And the cheats own the vast majority of 75K Puts that will expire in the money. And this has been happening for eight months since the fabulous, fantastic AdCom panel meeting on April 1. MAYBE one year calls will be enough time to get past the shenanigans, but who knows? I said a few months ago that no one should play much with options. Sadly I already owned Jan 2015 calls. My advice to new investors, ONLY buy shares to hold for the very long term, NOT options. SOMEDAY the PPS will go up if Afrezza is successful, but only God and Wall Street know when it will finally be allowed to trade without the current illegal manipulation. |
|
|
|
Post by xoxoxoxo on Jan 15, 2015 16:04:27 GMT -5
I closed out some of my $5 January 15 calls at the end of the year for the tax losses... Closing out the remainder of my calls tomorrow on expiration day for another loss.. Oh well. My goal at this point is for my shares to get back to where they were last year!
|
|
|
|
Post by alethea on Jan 15, 2015 17:23:27 GMT -5
Mannkind & Bank of America Conflicting Afrezza Survey's
by kevinmik • 6 hours ago
Despite Alfred Mann having a Private Banking relationship with Bank of America, Mannkind has entered into financial transactions with Bank of America specifically a stock lending arrangement that includes 9 millions shares and a $5.55 stock to be sold @ by BOA and Bank of America issuing ratings and price targets on Mannkind that as of September 2013, has an under perform rating with a price target of $5. Actually Bank of America lowered their price target last year to $4. Based on these circumstances a conflict of interest seems to be in play. I also find it interesting that both Mannkind & Bank of America are using Afrezza survey's to justify their stated positions in favor of or against the future success of Afrezza. I believe Mannkind stock price is being influenced by Bank of America, while Mannkind turns a blind eye. I look forward to Bank of America turning positive on Mannkind, that will be the start of a bull run for the stock price. Here is Bank of America's Sept. 2013 rating for Mannkind.
UPDATE: Bank of America Downgrades MannKind Following Physician Survey
September 06, 2013 11:02am
Bank of America analyst Steve Byrne downgraded the rating on MannKind Corporation from Neutral to Underperform, and lowered the price target from $8.00 to $5.00.
"In the report, Bank of America noted, “We lowered our rating to Underperform and our PO to $5 (from $8) following our recent 75 physician survey to assess interest levels in Afrezza post phase 3 results. Respondents were notably more cautious about Afrezza compared to our March survey, particularly regarding use in Type 2 diabetes patients on oral therapies. We now model peak share of 2% in the oral market (4% prev.). Our 4% peak share of the basal/prandial insulin market for type 1 patients is unchanged. We model Afrezza attaining 1.6% share of the US diabetes market by 2020, which may still be aggressive and largely depends on the quality of a much-needed partner.” Less
Reply to Ada
While Kevin posts a ton of stuff on Yahoo, some/much of it a bit nuts, I think he is spot on here.
|
|
Deleted
Deleted Member
Posts: 0
|
No Respect
Jan 15, 2015 17:32:45 GMT -5
via mobile
jpg likes this
Post by Deleted on Jan 15, 2015 17:32:45 GMT -5
That was pre ADCOM and pre approval for chrissake.
Btw, I've told Kevin this 100 times already but boa doesn't have the shares. They sold them. On closure of the note, boa either must return the shares or pay MNKD $50,000,000. So ya they want the price right here or lower
|
|
|
|
Post by dstevenson on Jan 15, 2015 17:35:38 GMT -5
when will the bull run start, tahts the question?>
|
|
|
|
Post by alethea on Jan 15, 2015 17:43:27 GMT -5
That was pre ADCOM and pre approval for chrissake. Btw, I've told Kevin this 100 times already but boa doesn't have the shares. They sold them. On closure of the note, boa either must return the shares or pay MNKD $50,000,000. So ya they want the price right here or lowerIsn't that the point? They want the price lower. So they can buy the 9M shares they must repay at the lowest possible price? |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 15, 2015 17:49:20 GMT -5
That was pre ADCOM and pre approval for chrissake. Btw, I've told Kevin this 100 times already but boa doesn't have the shares. They sold them. On closure of the note, boa either must return the shares or pay MNKD $50,000,000. So ya they want the price right here or lowerIsn't that the point? They want the price lower. So they can buy the 9M shares they must repay at the lowest possible price? And it has been sitting on this range for about a while now probably for a quarter.... whats stopping BAC to buy the stock in open market and end it? Its not like the daily volume is 1000 shares.. avg daily volume is 4 million |
|
|
|
Post by dstevenson on Jan 15, 2015 18:11:25 GMT -5
but i thought BAC and Al are buddies?
|
|
|
|
Post by alethea on Jan 15, 2015 18:22:39 GMT -5
Isn't that the point? They want the price lower. So they can buy the 9M shares they must repay at the lowest possible price? Nothing to stop them. I agree at some point they will be done. But not sure they are finished bleeding out longs on newly issued options. Maybe no need to kill the golden goose yet? |
|
|
|
Post by jpg on Jan 15, 2015 18:22:45 GMT -5
Isn't that the point? They want the price lower. So they can buy the 9M shares they must repay at the lowest possible price? And it has been sitting on this range for about a while now probably for a quarter.... whats stopping BAC to buy the stock in open market and end it? Its not like the daily volume is 1000 shares.. avg daily volume is 4 million Daily volume may be high but getting 9 million real shares could be hard. I wouldn't be surprised if the vast majority of the shares traded are ghost shares or the same shares going back and forth. Buying 9 million real shares could destabilize the current price structure (which could be very good for us obviously...). JPG |
|
Deleted
Deleted Member
Posts: 0
|
No Respect
Jan 15, 2015 18:28:19 GMT -5
via mobile
Post by Deleted on Jan 15, 2015 18:28:19 GMT -5
Yes it is the point, but a point in semantics.
|
|
|
|
Post by od on Jan 15, 2015 18:56:02 GMT -5
Anyone know how much a spirometer costs? Full spirometers that allow providers to bill payors - $1000 more, or less . There are less expensive devices that will provide FEV1 % Predicted data, but payors will not reimburse for this test. Pays for itself (and then some), especially if used for working-up COPD patients (standard of care that is not always attended to). |
|
Deleted
Deleted Member
Posts: 0
|
No Respect
Jan 15, 2015 19:51:31 GMT -5
via mobile
Post by Deleted on Jan 15, 2015 19:51:31 GMT -5
Anyone know how much a spirometer costs? Full spirometers that allow providers to bill payors - $1000 more, or less . There are less expensive devices that will provide FEV1 % Predicted data, but payors will not reimburse for this test. Pays for itself (and then some), especially if used for working-up COPD patients (standard of care that is not always attended to). I got one yearly for 14 yrs. They cost $40 and are negotiated down to about $18 thru insurance. |
|
